Literature DB >> 3980097

Systemic Chlamydia trachomatis infection in mice: a comparison of lymphogranuloma venereum and trachoma biovars.

R C Brunham, C Kuo, W J Chen.   

Abstract

We developed a murine model of systemic infection with Chlamydia trachomatis biovar lymphogranuloma venereum (LGV). The pathological features of this infection resemble those of human LGV infection since both are characterized by granuloma formation. Mice developed resistance to reinfection with LGV, and this resistance was based on cellular immune mechanisms since it was transferable with immune spleen cells but not with immune serum. Resistance required viable organisms for induction. We compared LGV biovar infection with trachoma biovar infection. Trachoma biovar produced similar but less marked microbiological and pathological features. Cross-immunity was less apparent between serovars from trachoma and LGV biovars than it was between serovars within the same biovar. This model of systemic C. trachomatis infection will be useful in exploring virulence features of LGV.

Entities:  

Mesh:

Year:  1985        PMID: 3980097      PMCID: PMC261917          DOI: 10.1128/iai.48.1.78-82.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

Review 1.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

Review 2.  The relationship of delayed hypersensitivity to acquired cellular resistance.

Authors:  G B Mackaness
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

3.  Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody.

Authors:  S P Wang; J T Grayston; E R Alexander; K K Holmes
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

4.  Serologic evidence for Chlamydia trachomatis myocarditis.

Authors:  R E Ringel; J I Brenner; M B Rennels; S W Huang; S P Wang; J T Grayston; M A Berman
Journal:  Pediatrics       Date:  1982-07       Impact factor: 7.124

5.  A mouse model of Chlamydia trachomatis pneumonitis.

Authors:  C Kuo; W J Chen
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

6.  Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells).

Authors:  C D Rothermel; G I Byrne; E A Havell
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, Chlamydia trachomatis.

Authors:  J Kazar; J D Gillmore; F B Gordon
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

8.  Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse.

Authors:  D M Williams; J Schachter; D J Drutz; C V Sumaya
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

9.  Chlamydia trachomatis endocarditis.

Authors:  J M van der Bel-Kahn; C Watanakunakorn; M G Menefee; H D Long; R Dicter
Journal:  Am Heart J       Date:  1978-05       Impact factor: 4.749

10.  Inhibition of the growth of Rickettsia prowazekii in cultured fibroblasts by lymphokines.

Authors:  J Turco; H H Winkler
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

3.  Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis.

Authors:  S J Rasmussen; L Eckmann; A J Quayle; L Shen; Y X Zhang; D J Anderson; J Fierer; R S Stephens; M F Kagnoff
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.

Authors:  J I Ito; J M Lyons; L P Airo-Brown
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Differences in susceptibilities of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis to neutralization by immune sera.

Authors:  E M Peterson; M Hoshiko; B A Markoff; M W Lauermann; L M de la Maza
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

6.  Selective infection of astrocytes by Chlamydia trachomatis in primary mixed neuron-glial cell cultures.

Authors:  D Levitt; R Danen; P Levitt
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Monitoring the T cell response to genital tract infection.

Authors:  Nadia R Roan; Todd M Gierahn; Darren E Higgins; Michael N Starnbach
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

8.  Immune responses of mice after conjunctival exposure to Chlamydia trachomatis serovar A.

Authors:  I S Barsoum; L K Hardin; D G Colley
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

9.  Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections.

Authors:  G M Zhong; E M Peterson; C W Czarniecki; R D Schreiber; L M de la Maza
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

10.  Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates.

Authors:  S P James; A S Graeff; M Zeitz; E Kappus; T C Quinn
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.